Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Convertible Debt (2023)

Historic Convertible Debt for Q32 Bio (QTTB) over the last 1 years, with Q4 2023 value amounting to $38.6 million.

  • Q32 Bio's Convertible Debt changed N/A to $38.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $38.6 million, marking a year-over-year change of. This contributed to the annual value of $38.6 million for FY2023, which is N/A changed from last year.
  • Per Q32 Bio's latest filing, its Convertible Debt stood at $38.6 million for Q4 2023.
  • Q32 Bio's 5-year Convertible Debt high stood at $38.6 million for Q4 2023, and its period low was $38.6 million during Q4 2023.